Combirucan Tablet 5/8 mg

Adult dose

Candesartan Cilexetil for essential hypertension: the initial and maintenance dose is recommended as 8-16 mg orally once daily. If blood pressure is not adequately controlled, the dose may be increased to a maximum of 32 mg once daily. Heart failure: initial dose of 4 mg once daily, increased by doubling the dose at intervals of 2 weeks or more, with a maximum of 32 mg once daily. Rosuvastatin: initial dose of 5 mg once daily.

Child dose

Safety and efficacy in adolescents and children under 18 years of age have not been established.

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug, liver disease, severe liver dysfunction, renal failure, and myopathy should not take this medication. Women of childbearing potential should only take this medication if they fully understand the possibility of pregnancy and risks to the fetus, and should use appropriate contraceptive methods. Elderly patients or those with liver dysfunction, renal dysfunction, or hyperkalemia should use this medication carefully, and regular blood tests and liver function tests may be required during treatment. This medication may cause muscle-related side effects such as myalgia, myopathy, and rhabdomyolysis; if unexplained muscle pain or weakness occurs during treatment, consult a doctor immediately. This medication may affect liver function, so liver enzyme levels should be checked before and during treatment, and if liver dysfunction is severe, administration should be discontinued. Due to its blood pressure-lowering effects, hypotension or dizziness may occur, so caution is needed when driving or operating machinery. When used in combination with other antihypertensive medications or diuretics, potassium-sparing diuretics, etc., blood pressure, kidney function, and serum potassium levels should be monitored regularly. This medication may interact with certain drugs, so be sure to inform healthcare professionals about any other medications being taken. Pregnant or breastfeeding women should not take this medication, and breastfeeding should be discontinued if necessary. Safety in children has not been established, and use is not recommended. In case of overdose, appropriate treatment is required depending on the symptoms, and this medication is not removed by dialysis. When storing this medication, keep it out of the reach of children and store it in its original container.

Serious side effects

Hives, angioedema, chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in oral/eye mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory complications accompanied by cough and fever, respiratory issues, jaundice (yellowing of skin or eyes), extreme lethargy, liver dysfunction (jaundice), sudden and severe

Mild side effects

• Headache
• dizziness
• rhinitis
• fatigue
• itching
• dermatitis
• joint stiffness
• limb pain
• glare
• dyspepsia

This medication should be stored in a tightly closed container to prevent air or moisture from entering and kept at room temperature between 1°C and 30°C. This will help maintain the drug's effectiveness for a longer period.

Appearance

Pink round film-coated tablets

Package unit

30 tablets (10 tablets/PTP X 3)